カイノスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/06/26 | 1,202 | 1,208 | 1,197 | 1,202 | -5 | -0.4% | 2,000 |
| 2024/06/25 | 1,207 | 1,210 | 1,196 | 1,207 | -6 | -0.5% | 3,700 |
| 2024/06/24 | 1,212 | 1,214 | 1,182 | 1,213 | +12 | +1% | 4,500 |
| 2024/06/21 | 1,211 | 1,211 | 1,200 | 1,201 | -2 | -0.2% | 2,300 |
| 2024/06/20 | 1,215 | 1,215 | 1,203 | 1,203 | -12 | -1% | 2,500 |
| 2024/06/19 | 1,179 | 1,215 | 1,179 | 1,215 | +37 | +3.1% | 8,100 |
| 2024/06/18 | 1,179 | 1,183 | 1,175 | 1,178 | +4 | +0.3% | 6,500 |
| 2024/06/17 | 1,151 | 1,174 | 1,151 | 1,174 | +13 | +1.1% | 6,300 |
| 2024/06/14 | 1,158 | 1,168 | 1,158 | 1,161 | +5 | +0.4% | 4,400 |
| 2024/06/13 | 1,152 | 1,158 | 1,150 | 1,156 | +11 | +1% | 3,800 |
| 2024/06/12 | 1,148 | 1,155 | 1,145 | 1,145 | -3 | -0.3% | 2,800 |
| 2024/06/11 | 1,149 | 1,152 | 1,140 | 1,148 | +8 | +0.7% | 2,300 |
| 2024/06/10 | 1,137 | 1,153 | 1,137 | 1,140 | +4 | +0.4% | 7,500 |
| 2024/06/07 | 1,147 | 1,151 | 1,136 | 1,136 | -17 | -1.5% | 4,200 |
| 2024/06/06 | 1,147 | 1,154 | 1,142 | 1,153 | ±0 | ±0% | 1,300 |
| 2024/06/05 | 1,145 | 1,154 | 1,141 | 1,153 | +8 | +0.7% | 3,200 |
| 2024/06/04 | 1,138 | 1,156 | 1,137 | 1,145 | +7 | +0.6% | 2,700 |
| 2024/06/03 | 1,135 | 1,158 | 1,130 | 1,138 | +2 | +0.2% | 11,700 |
| 2024/05/31 | 1,139 | 1,151 | 1,136 | 1,136 | -3 | -0.3% | 1,900 |
| 2024/05/30 | 1,152 | 1,152 | 1,136 | 1,139 | -3 | -0.3% | 1,600 |
| 2024/05/29 | 1,145 | 1,154 | 1,142 | 1,142 | -3 | -0.3% | 5,300 |
| 2024/05/28 | 1,129 | 1,158 | 1,129 | 1,145 | +7 | +0.6% | 3,300 |
| 2024/05/27 | 1,131 | 1,141 | 1,131 | 1,138 | -1 | -0.1% | 2,700 |
| 2024/05/24 | 1,135 | 1,149 | 1,135 | 1,139 | -1 | -0.1% | 700 |
| 2024/05/23 | 1,149 | 1,157 | 1,138 | 1,140 | -9 | -0.8% | 6,300 |
| 2024/05/22 | 1,153 | 1,153 | 1,144 | 1,149 | -4 | -0.3% | 1,300 |
| 2024/05/21 | 1,159 | 1,159 | 1,143 | 1,153 | -6 | -0.5% | 2,300 |
| 2024/05/20 | 1,148 | 1,160 | 1,134 | 1,159 | +11 | +1% | 5,500 |
| 2024/05/17 | 1,132 | 1,149 | 1,130 | 1,148 | +5 | +0.4% | 1,600 |
| 2024/05/16 | 1,141 | 1,149 | 1,132 | 1,143 | +3 | +0.3% | 1,300 |
| 2024/05/15 | 1,130 | 1,164 | 1,120 | 1,140 | +7 | +0.6% | 27,000 |
| 2024/05/14 | 1,142 | 1,144 | 1,133 | 1,133 | -12 | -1% | 3,500 |
| 2024/05/13 | 1,152 | 1,164 | 1,140 | 1,145 | -7 | -0.6% | 11,800 |
| 2024/05/10 | 1,138 | 1,155 | 1,134 | 1,152 | +19 | +1.7% | 17,900 |
| 2024/05/09 | 1,230 | 1,245 | 1,131 | 1,133 | -89 | -7.3% | 74,000 |
| 2024/05/08 | 1,214 | 1,223 | 1,214 | 1,222 | +8 | +0.7% | 1,100 |
| 2024/05/07 | 1,199 | 1,224 | 1,199 | 1,214 | +6 | +0.5% | 6,400 |
| 2024/05/02 | 1,196 | 1,208 | 1,196 | 1,208 | +8 | +0.7% | 900 |
| 2024/05/01 | 1,202 | 1,209 | 1,200 | 1,200 | -2 | -0.2% | 1,800 |
| 2024/04/30 | 1,212 | 1,212 | 1,195 | 1,202 | -10 | -0.8% | 9,200 |
| 2024/04/26 | 1,201 | 1,212 | 1,191 | 1,212 | +2 | +0.2% | 3,400 |
| 2024/04/25 | 1,225 | 1,227 | 1,203 | 1,210 | -1 | -0.1% | 16,700 |
| 2024/04/24 | 1,202 | 1,211 | 1,202 | 1,211 | +7 | +0.6% | 1,900 |
| 2024/04/23 | 1,200 | 1,219 | 1,200 | 1,204 | +12 | +1% | 4,100 |
| 2024/04/22 | 1,190 | 1,205 | 1,190 | 1,192 | +7 | +0.6% | 2,200 |
| 2024/04/19 | 1,202 | 1,206 | 1,170 | 1,185 | -17 | -1.4% | 7,500 |
| 2024/04/18 | 1,209 | 1,209 | 1,197 | 1,202 | -9 | -0.7% | 800 |
| 2024/04/17 | 1,204 | 1,213 | 1,181 | 1,211 | +2 | +0.2% | 3,300 |
| 2024/04/16 | 1,210 | 1,229 | 1,205 | 1,209 | -1 | -0.1% | 2,000 |
| 2024/04/15 | 1,218 | 1,229 | 1,210 | 1,210 | -8 | -0.7% | 1,600 |
101～
150
件表示中 / 3585件
類似銘柄と比較する
現在ご覧いただいている「カイノス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| カイノス | 120,300円 | +6.8% | -13.8% | 2.66% | 9.22倍 | 0.78倍 |
|
臨床検査薬の中堅メーカー。生化学、免疫血清学的検査用試薬に重点。共同開発の促進に注力 |
| ＶＩＳ | 90,500円 | +87.8% | +265.7% | 0.00% | 54.35倍 | 2.49倍 |
|
ｍＲＮＡ標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
| クリングル | 86,000円 | +240.0% | - | 0.00% | - | 2.80倍 |
|
細胞の増殖、保護、修復などの機能があるＨＧＦタンパク質を用いて、難治性疾患治療薬を開発 |
| キッズバイオ | 11,800円 | - | - | 0.00% | - | 6.21倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞（ＳＨＥＤ）用いた再生医療に力 |
| ＤＥＬＴＡ－Ｐ | 52,300円 | - | - | 0.00% | - | 15.01倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
市場注目の銘柄
チャート関連のコラム
